Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Prepublished online as a Blood First Edition Paper on October 10, 2002; DOI 10.1182/blood-2002-05-1329.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2002-05-1329v1
101/4/1367    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Matsumura, K.
Right arrow Articles by Nishikawa, S.-I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Matsumura, K.
Right arrow Articles by Nishikawa, S.-I.
Related Collections
Right arrow Hemostasis, Thrombosis, and Vascular Biology
Right arrow Signal Transduction
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

Blood, 15 February 2003, Vol. 101, No. 4, pp. 1367-1374

HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY

Modulation of VEGFR-2-mediated endothelial-cell activity by VEGF-C/VEGFR-3

Kazuyoshi Matsumura, Masanori Hirashima, Minetaro Ogawa, Hajime Kubo, Hiroshi Hisatsune, Nobuyuki Kondo, Satomi Nishikawa, Tsutomu Chiba, and Shin-Ichi Nishikawa

From the Division of Gastroenterology and Hepatology, Department of Internal Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan; the Department of Molecular Genetics, Graduate School of Medicine, Kyoto University, Kyoto, Japan; and the Stem Cell Biology Laboratory, Center for Developmental Biology, Kobe, Japan.

Vascular endothelial growth factor (VEGF) receptor 3 (VEGFR-3), a receptor for VEGF-C, was shown to be essential for angiogenesis as well as for lymphangiogenesis. Targeted disruption of the VEGFR-3 gene in mice and our previous study using an antagonistic monoclonal antibody (MoAb) for VEGFR-3 suggested that VEGF-C/VEGFR-3 signals might be involved in the maintenance of vascular integrity. In this study we used an in vitro embryonic stem (ES) cell culture system to maintain the VEGFR-3+ endothelial cell (EC) and investigated the role of VEGFR-3 signals at the cellular level. In this system packed clusters of ECs were formed. Whereas addition of exogenous VEGF-A induced EC dispersion, VEGF-C, which can also stimulate VEGFR-2, promoted EC growth without disturbing the EC clusters. Moreover, addition of AFL4, an antagonistic MoAb for VEGFR-3, resulted in EC dispersion. Cytological analysis showed that VEGF-A- and AFL4-treated ECs were indistinguishable in many aspects but were distinct from the cytological profile induced by antagonistic MoAb for VE-cadherin (VECD-1). As AFL4- induced EC dispersion requires VEGF-A stimulation, it is likely that VEGFR-3 signals negatively modulate VEGFR-2. This result provides new insights into the involvement of VEGFR-3 signals in the maintenance of vascular integrity through modulation of VEGFR-2 signals. Moreover, our findings suggest that the mechanisms underlying AFL4-induced EC dispersion are distinct from those underlying VECD-1-induced dispersion for maintenance of EC integrity.

© 2003 by The American Society of Hematology.
 

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
T. Kono, H. Kubo, C. Shimazu, Y. Ueda, M. Takahashi, K. Yanagi, N. Fujita, T. Tsuruo, H. Wada, and J. K. Yamashita
Differentiation of Lymphatic Endothelial Cells From Embryonic Stem Cells on OP9 Stromal Cells
Arterioscler. Thromb. Vasc. Biol., September 1, 2006; 26(9): 2070 - 2076.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
L. D. Covassin, J. A. Villefranc, M. C. Kacergis, B. M. Weinstein, and N. D. Lawson
Distinct genetic interactions between multiple Vegf receptors are required for development of different blood vessel types in zebrafish
PNAS, April 25, 2006; 103(17): 6554 - 6559.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
I. Hamaguchi, T. Morisada, M. Azuma, K. Murakami, M. Kuramitsu, T. Mizukami, K. Ohbo, K. Yamaguchi, Y. Oike, D. J. Dumont, et al.
Loss of Tie2 receptor compromises embryonic stem cell-derived endothelial but not hematopoietic cell survival
Blood, February 1, 2006; 107(3): 1207 - 1213.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. Salameh, F. Galvagni, M. Bardelli, F. Bussolino, and S. Oliviero
Direct recruitment of CRK and GRB2 to VEGFR-3 induces proliferation, migration, and survival of endothelial cells through the activation of ERK, AKT, and JNK pathways
Blood, November 15, 2005; 106(10): 3423 - 3431.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
T. Morisada, Y. Oike, Y. Yamada, T. Urano, M. Akao, Y. Kubota, H. Maekawa, Y. Kimura, M. Ohmura, T. Miyamoto, et al.
Angiopoietin-1 promotes LYVE-1-positive lymphatic vessel formation
Blood, June 15, 2005; 105(12): 4649 - 4656.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
H. Suzuki, T. Watabe, M. Kato, K. Miyazawa, and K. Miyazono
Roles of vascular endothelial growth factor receptor 3 signaling in differentiation of mouse embryonic stem cell-derived vascular progenitor cells into endothelial cells
Blood, March 15, 2005; 105(6): 2372 - 2379.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
D. J. Hicklin and L. M. Ellis
Role of the Vascular Endothelial Growth Factor Pathway in Tumor Growth and Angiogenesis
J. Clin. Oncol., February 10, 2005; 23(5): 1011 - 1027.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Furuyama, K. Kitayama, Y. Shimoda, M. Ogawa, K. Sone, K. Yoshida-Araki, H. Hisatsune, S.-i. Nishikawa, K. Nakayama, K. Nakayama, et al.
Abnormal Angiogenesis in Foxo1 (Fkhr)-deficient Mice
J. Biol. Chem., August 13, 2004; 279(33): 34741 - 34749.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Dixelius, T. Makinen, M. Wirzenius, M. J. Karkkainen, C. Wernstedt, K. Alitalo, and L. Claesson-Welsh
Ligand-induced Vascular Endothelial Growth Factor Receptor-3 (VEGFR-3) Heterodimerization with VEGFR-2 in Primary Lymphatic Endothelial Cells Regulates Tyrosine Phosphorylation Sites
J. Biol. Chem., October 17, 2003; 278(42): 40973 - 40979.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2003 by American Society of Hematology         Online ISSN: 1528-0020